SUBRETINAL FIBROSIS AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION
- Authors
- Ahn, Seong Joon; Park, Kyu Hyung; Woo, Se Joon
- Issue Date
- Nov-2016
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Keywords
- antivascular endothelial growth factor; choroidal neovascularization; pathologic myopia; subretinal fibrosis; visual outcome
- Citation
- RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, v.36, no.11, pp.2140 - 2149
- Indexed
- SCIE
SCOPUS
- Journal Title
- RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Volume
- 36
- Number
- 11
- Start Page
- 2140
- End Page
- 2149
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153616
- DOI
- 10.1097/IAE.0000000000001043
- ISSN
- 0275-004X
- Abstract
- Purpose: To assess the incidence and risk factors of subretinal fibrosis and their impact on visual outcome in eyes with myopic CNV.
Methods: Medical records of 72 eyes treated with antivascular endothelial growth factor (anti-VEGF) therapy in a pro re nata regimen for myopic CNV that followed up for more than 1 year were retrospectively reviewed. The presence of subretinal fibrosis after anti-VEGF therapy was determined using both fundus photographs and optical coherence tomography. The incidence and risk factors of subretinal fibrosis were evaluated, and best-corrected visual acuity was compared between the eyes with and without subretinal fibrosis.
Results: The incidences of subretinal fibrosis during the 1-year and whole follow-up period were 31.9% and 36.1%, respectively. Occurrence of subretinal fibrosis was associated with frequent CNV recurrence (P = 0.005) and poor baseline best-corrected visual acuity (P = 0.044) in a Cox proportional hazard model. Anatomically, the eyes with subretinal fibrosis showed more frequent progression of chorioretinal atrophy (95.7% vs. 71.4%, P = 0.027) and less frequent photoreceptor recovery (17.4% vs. 65.3%, P < 0.001) after anti-VEGF therapy. Occurrence of subretinal fibrosis was associated with poor vision at baseline (P = 0.011) and the final visit (P = 0.008) when compared with the findings in the nonoccurrence group.
Conclusion: Development of subretinal fibrosis after anti-VEGF therapy was common in eyes with myopic CNV and was associated with CNV recurrence. Myopic eyes with subretinal fibrosis show progressive chorioretinal atrophy and poor visual outcome.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 안과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153616)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.